Added to YB: 2024-07-18
Pitch date: 2024-07-18
ACET [bullish]
Adicet Bio, Inc.
-60.42%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Adicet Bio, Inc., a clinical stage biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for autoimmune diseases and cancer in the United States.
Market Cap
$52.8M
Pitch Price
$1.26
Price Target
N/A
Dividend
N/A
EV/EBITDA
0.91
P/E
-0.48
EV/Sales
N/A
Sector
Biotechnology
Category
N/A
Show full summary:
ADICET BIO INC ACET
A summary for this pitch has not been created yet.
Read full article (0 min)